Precision Oncology Market Research Report Information By Product Type (Diagnostics and Therapeutics), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Skin Cancer, Prostate Cancer, Stomach Cancer and Other), By End-user (Hospitals, Diagnostic Centers, Research & Academic Institutes and Other) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Diagnostics

6.3. Therapeutics

7. GLOBAL PRECISION ONCOLOGY MARKET, BY CANCER TYPE

7.1. Overview

7.2. Breast Cancer

7.3. Lung Cancer

7.4. Colorectal Cancer

7.5. Skin Cancer

7.6. Prostate Cancer

7.7. Stomach Cancer

7.8. Other

8. GLOBAL PRECISION ONCOLOGY MARKET, BY END-USER

8.1. Overview

8.2. Hospitals

8.3. Diagnostic Centers

8.4. Research & Academic Institutes

8.5. Other

9. GLOBAL PRECISION ONCOLOGY MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Precision Oncology Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Precision Oncology Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Roche

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Illumina, Inc.

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Thermo Fisher Scientific Inc.

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Qiagen N.V.

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Agilent Technologies, Inc.

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Foundation Medicine, Inc.

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Myriad Genetics, Inc.

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Guardant Health, Inc.

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. NanoString Technologies, Inc.

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Exact Sciences Corporation

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PRECISION ONCOLOGY MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL PRECISION ONCOLOGY MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 9 US: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 10 US: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 11 US: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 12 CANADA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 13 CANADA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 14 CANADA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 10 ITALY: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 11 ITALY: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 12 ITALY: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 16 UK: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 17 UK: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 18 UK: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 28 CHINA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 29 CHINA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 30 CHINA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 31 INDIA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 32 INDIA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 33 INDIA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: PRECISION ONCOLOGY MARKET, BY CANCER TYPE, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: PRECISION ONCOLOGY MARKET, BY END-USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PRECISION ONCOLOGY MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PRECISION ONCOLOGY MARKET

FIGURE 4 GLOBAL PRECISION ONCOLOGY MARKET, SHARE (%), BY PRODUCT TYPE, 2023

FIGURE 5 GLOBAL PRECISION ONCOLOGY MARKET, SHARE (%), BY CANCER TYPE, 2023

FIGURE 6 GLOBAL PRECISION ONCOLOGY MARKET, SHARE (%), BY END-USER, 2023

FIGURE 7 GLOBAL PRECISION ONCOLOGY MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: PRECISION ONCOLOGY MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: PRECISION ONCOLOGY MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: PRECISION ONCOLOGY MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: PRECISION ONCOLOGY MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL PRECISION ONCOLOGY MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 ROCHE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 ROCHE: SWOT ANALYSIS

FIGURE 15 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 ILLUMINA, INC.: SWOT ANALYSIS

FIGURE 17 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

FIGURE 19 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 QIAGEN N.V.: SWOT ANALYSIS

FIGURE 21 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS

FIGURE 23 FOUNDATION MEDICINE, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 FOUNDATION MEDICINE, INC.: SWOT ANALYSIS

FIGURE 25 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 MYRIAD GENETICS, INC.: SWOT ANALYSIS

FIGURE 27 GUARDANT HEALTH, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 GUARDANT HEALTH, INC.: SWOT ANALYSIS

FIGURE 29 NANOSTRING TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 NANOSTRING TECHNOLOGIES, INC.: SWOT ANALYSIS

FIGURE 31 EXACT SCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 EXACT SCIENCES CORPORATION: SWOT ANALYSIS